Synriam (Arterolane Maleate and Piperaquine Phosphate)
Overview
Synriam is a combination antimalarial medication containing Arterolane Maleate and Piperaquine Phosphate, used for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum. Synriam provides fast and effective relief from malaria symptoms such as fever, chills, and fatigue. This fixed-dose combination works by targeting the malaria parasite at different stages of its lifecycle, helping to clear the infection quickly and prevent recurrence. Synriam is known for its convenient once-daily dosing, making it an easy and effective choice for malaria treatment.
Benefits of Synriam
- Effective malaria treatment: Targets and eliminates Plasmodium falciparum, the parasite responsible for most cases of malaria.
- Rapid symptom relief: Provides fast relief from malaria symptoms, including fever, chills, body aches, and fatigue.
- Once-daily dosing: Easy to take with a convenient once-daily dose for three days, improving patient compliance.
- Prevents recurrence: Reduces the risk of malaria relapse by targeting different stages of the parasite's lifecycle.
Who Can Use It?
- Individuals with uncomplicated malaria: Suitable for adults and children over 12 years of age diagnosed with Plasmodium falciparum malaria.
- Travelers returning from malaria-endemic regions: Beneficial for individuals who have contracted malaria after traveling to areas where the disease is common.
How to Use
- Take one tablet once daily for three consecutive days, as prescribed by your healthcare provider.
- Swallow the tablet whole with water, preferably after a meal to improve absorption and reduce the risk of stomach upset.
Precautions
- Not suitable for children under 12 years of age.
- Consult your healthcare provider if you have liver or kidney disease, or if you are pregnant or breastfeeding.
- Possible side effects include nausea, headache, dizziness, or weakness. Contact your doctor if you experience severe side effects.